ES2067916T3 - Matriz con celulas fijadas por adherencia y procedimiento de produccion de virus/antigenos de virus. - Google Patents

Matriz con celulas fijadas por adherencia y procedimiento de produccion de virus/antigenos de virus.

Info

Publication number
ES2067916T3
ES2067916T3 ES91900666T ES91900666T ES2067916T3 ES 2067916 T3 ES2067916 T3 ES 2067916T3 ES 91900666 T ES91900666 T ES 91900666T ES 91900666 T ES91900666 T ES 91900666T ES 2067916 T3 ES2067916 T3 ES 2067916T3
Authority
ES
Spain
Prior art keywords
virus
cells
matrix
viruses
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900666T
Other languages
English (en)
Inventor
Wolfgang Mundt
Noel Barrett
Friedrich Dorner
Johann Eibl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Application granted granted Critical
Publication of ES2067916T3 publication Critical patent/ES2067916T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00—Microcarriers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

MATRIZ CON CELULAS UNIDAS ADHERENTES A ELLA, ASI COMO PROCEDIMIENTO PARA LA PRODUCCION DE VIRUS/ANTIGENOS DE VIRUS. LA INVENCION CONSTA DE UNA MATRIZ, ES DECIR UN MATERIAL DE SOPORTE, CON CELULAS HUMANAS O ANIMALES UNIDAS ADHERENTEMENTE A ELLA, ESTANDO LAS CELULAS INFECTADAS CON VIRUS. SE HA MOSTRADO QUE LAS CELULAS DEPENDIENTES DE LA SUPERFICIE, QUE SON APROPIADAS PARA LA MULTIPLICACION DE LOS VIRUS, INCLUSO EN ESTADO INFECTADO POR VIRUS PERMANECEN ADHERIDAS A UNA MATRIZ, PRODUCEN ANTIGENOS DE VIRUS DE FORMA CONSTANTE A LO LARGO DE UN TIEMPO RELATIVAMENTE LARGO Y LOS CEDEN AL MEDIO DE CULTIVO. PARA LA PRODUCCION DEL ANTIGENO DEL VIRUS DE LA MENINGOENCEFALITIS ESTIVAL (FSME) MEDIANTE CULTIVO DEL VIRUS FSME EN CULTIVOS CELULARES SE VACUNA CON EL VIRUS FSME UNA LINEA CELULAR PERMANENTE DEPENDIENTE DE LA SUPERFICIE, PREFERENTEMENTE LA LINEA CELULAR VERO ATTC CCL 81, Y LAS CELULAS SE MANTIENEN UNIDAS A SOPORTES CONSERVANDO EL CRECIMIENTO CELULAR EN UN SISTEMA SIN SUERO NO LITICO, PARA CONSERVARLA FORMACION DE ANTIGENOS, SEPARANDO A CONTINUACION EL MEDIO QUE CONTIENE LOS ANTIGENOS DE LAS CELULAS UNIDAS AL SOPORTE Y DE FORMA CONOCIDA MEDIANTE CONCENTRACION, INACTIVACION Y PURIFICACION SE PREPARA UN COMPUESTO GALENICO ACEPTABLE.
ES91900666T 1989-12-22 1990-12-21 Matriz con celulas fijadas por adherencia y procedimiento de produccion de virus/antigenos de virus. Expired - Lifetime ES2067916T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT2928/89A AT393356B (de) 1989-12-22 1989-12-22 Verfahren zur herstellung von fsme-virus-antigen

Publications (1)

Publication Number Publication Date
ES2067916T3 true ES2067916T3 (es) 1995-04-01

Family

ID=3542524

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900666T Expired - Lifetime ES2067916T3 (es) 1989-12-22 1990-12-21 Matriz con celulas fijadas por adherencia y procedimiento de produccion de virus/antigenos de virus.

Country Status (16)

Country Link
EP (1) EP0506714B1 (es)
JP (1) JP2633391B2 (es)
AT (2) AT393356B (es)
CA (1) CA2071954C (es)
CZ (1) CZ281804B6 (es)
DE (1) DE59007659D1 (es)
DK (1) DK0506714T3 (es)
ES (1) ES2067916T3 (es)
FI (1) FI98377C (es)
HR (1) HRP921354A2 (es)
HU (1) HU213886B (es)
NO (1) NO310305B1 (es)
RU (1) RU2082757C1 (es)
SK (1) SK659090A3 (es)
WO (1) WO1991009935A1 (es)
YU (1) YU242390A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2205015C (en) * 1994-11-10 2003-04-08 Otfried Kistner Method for producing biologicals in protein-free culture
CN1122531C (zh) * 1995-08-01 2003-10-01 巴斯德梅诺血清和疫苗公司 抗日本脑炎疫苗的工业生产方法和所获得的疫苗
FR2737412B1 (fr) * 1995-08-01 1997-10-24 Pasteur Merieux Serums Vacc Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede
KR20010032699A (ko) * 1998-10-05 2001-04-25 무따이 마사히꼬 일본 뇌염 바이러스 감염에 대한 불활성 백신을 위한증강된 면역원 및 그 제조방법
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus
US6951752B2 (en) 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
JP2007068401A (ja) * 2003-08-07 2007-03-22 Chemo Sero Therapeut Res Inst 西ナイルウイルスワクチン
SG187397A1 (en) * 2007-12-27 2013-02-28 Baxter Int Cell culture processes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358167B (de) * 1978-12-22 1980-08-25 Immuno Ag Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
SE445116B (sv) * 1979-09-12 1986-06-02 Pharmacia Fine Chemicals Ab Sett att odla celler pa mikroberare med fibronektinytskikt
NO161446C (no) * 1981-03-13 1989-08-16 Damon Biotech Inc Fremgangsmaate for dyrking av celler som er avhengige av forankring.
SE8103138L (sv) * 1981-05-19 1982-11-20 Pharmacia Fine Chemicals Ab Mikroberare for odling av forankringsberoende celler
CA1206900A (en) * 1981-12-21 1986-07-02 Raymond L. Downs Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture
AT385203B (de) * 1985-04-26 1988-03-10 Immuno Ag Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine
DD274336A3 (de) * 1985-10-03 1989-12-20 Npo Biolar Verfahren zur Gewinnung einer Mikroträgersubstanz für die Zellkultivierung

Also Published As

Publication number Publication date
ATE113652T1 (de) 1994-11-15
HU9202009D0 (en) 1992-10-28
WO1991009935A1 (de) 1991-07-11
AT393356B (de) 1991-10-10
NO922422L (no) 1992-08-17
YU242390A (sh) 1993-05-28
NO922422D0 (no) 1992-06-19
HU213886B (en) 1997-11-28
HUT65410A (en) 1994-06-28
DK0506714T3 (da) 1995-04-18
DE59007659D1 (de) 1994-12-08
RU2082757C1 (ru) 1997-06-27
FI922851A0 (fi) 1992-06-18
SK279236B6 (sk) 1998-08-05
ATA292889A (de) 1991-03-15
CA2071954C (en) 1996-06-18
JP2633391B2 (ja) 1997-07-23
HRP921354A2 (en) 1996-02-29
EP0506714A1 (de) 1992-10-07
FI922851A7 (fi) 1992-06-18
JPH05502581A (ja) 1993-05-13
FI98377C (fi) 1997-06-10
CA2071954A1 (en) 1991-06-23
EP0506714B1 (de) 1994-11-02
NO310305B1 (no) 2001-06-18
CZ659090A3 (en) 1996-11-13
CZ281804B6 (cs) 1997-02-12
FI98377B (fi) 1997-02-28
SK659090A3 (en) 1998-08-05

Similar Documents

Publication Publication Date Title
AR032575A1 (es) Uso de una preparacion antigenica de gripe para la fabricacion de una vacuna intradermica de la gripe y estuche farmaceutico que comprende dicha vacuna
Wang et al. Establishment and characterization of a cell line from tilapia brain for detection of tilapia lake virus
EA200200604A1 (ru) Производство вакцин
ES2067916T3 (es) Matriz con celulas fijadas por adherencia y procedimiento de produccion de virus/antigenos de virus.
CY1110716T1 (el) Πολλαπλασιασμος ιων εντος κυτταροκαλλιεργειας
ATE398672T1 (de) Immortalisierte vogelzellinien zur virusproduktion
ES2144051T3 (es) Cebo y trampa.
ES2042828T3 (es) Procedimiento de preparacion de vacunas contra tumores modificadas por virus para la inmunoterapia de metastasis de tumores.
AR033993A1 (es) Metodo para producir reovirus infeccioso y de mamifero, y composicion de reovirus
ES2038689T3 (es) Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido.
Kim et al. Generation of G gene-deleted viral hemorrhagic septicemia virus (VHSV) and evaluation of its vaccine potential in olive flounder (Paralichthys olivaceus)
O’Donnell et al. Virus–host interactions in persistently FMDV-infected cells derived from bovine pharynx
DK0480949T3 (da) Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
ES498752A0 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
Potgieter et al. Pneumonia in Ottoman vipers (Vipera xanthena xanthena) associated with a parainfluenza 2-like virus
Arimilli et al. Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function
AR072150A1 (es) Metodo de replicacion del virus de la influenza en suspension
Cole Jr et al. Persistent infection of human conjunctiva cell cultures by myxovirus parainfluenza 3
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
EP4410970A3 (en) Efficient cell culture system for hepatitis c virus genotype 6a
Peleg Behaviour of infectious RNA from four different viruses in continuously subcultured Aedes aegypti mosquito embryo cells
Mettler et al. Propagation of Junin virus, the etiological agent of Argentinian hemorrhagic fever, in HeLa cell cultures
Hampar Persistent Cyclic Herpes Simplex Virus Infection In Vitro II. Localization of Virus, Degree of Cell Destruction, and Mechanisms of Virus Transmission
Igarashi A mutant of chikungunya virus isolated from a line of Singh's Aedes albopictus cells by plaque formation on virus-sensitive cloned cells obtained from another Singh's A. albopictus cell line

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506714

Country of ref document: ES